CSI Market
Sign In | Register

Psyence Biomedical ltd (PBM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PBM Annual Balance Sheets →
The table below presents a historical view of Psyence Biomedical ltd's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Mar 31 2025) (Mar 31 2024) 0 0
Assets
Cash And Cash Equivalents7.15
Cash & Short-term Investments7.00
Other Current Assets0.00
Total Current Assets7.63
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent5.65
Total Assets12.81
Liabilities
Accounts Payable0.00
Other Liabilities, Current0.00
Deferred Liability and Revenue0.30
Total Current Liabilities0.30
Total Long-term Debt0.00
Other liabilities, Noncurrent0.64
Total Liabilities0.94
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity11.87
Total Stockholder's Equity11.87
Liabilities & Stockholder's Equity12.81
4 historic quarters locked

Sign in to unlock the full Psyence Biomedical ltd balance sheet history.

Sign In Create Free Account

About Psyence Biomedical Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-070607

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.